Echoviruses are the main causative agents of aseptic meningitis worldwide and are particularly 53 devastating in the neonatal population, where they are associated with severe hepatitis, 54 neurological disease including meningitis and encephalitis, and even death. Here, we identify the 55 neonatal Fc receptor (FcRn) as a pan-echovirus receptor. We show that loss of expression of 56 FcRn or its binding partner beta 2 microglubulin (b2M) renders human brain microvascular cells 57 resistant to infection by a panel of echoviruses at the stage of virus attachment and that a blocking 58 antibody to b2M inhibit echovirus infection in cell lines and in primary human fetal intestinal 59 epithelial cells. We also show that expression of human, but not mouse, FcRn renders non-60 permissive human and mouse cells sensitive to echovirus infection and that the extracellular 61 domain of human FcRn directly binds echoviral particles and neutralizes infection. Lastly, we 62 show that primary cells isolated from mice that express human FcRn are highly susceptible to 63 echovirus infection. Our findings thus identify FcRn as a pan-echovirus receptor, which may 64 explain the enhanced susceptibility of neonates to echovirus infections. 65 66 Significance 67 68 Echoviruses are associated with aseptic meningitis and induce severe disease, and even death, 69 in neonates and young infants. Here, we identify the neonatal Fc receptor (FcRn) as a pan-70 echovirus receptor. FcRn is expressed on the surface of the human placenta, and throughout life 71 in intestinal enterocytes, liver hepatocytes, and in the microvascular endothelial cells that line the 72 blood-brain barrier. This pattern of expression is consistent with the organ sites targeted by 73 echoviruses in humans, with the primary entry site of infection in the intestinal tract and 74
Echoviruses are small (~30nm) single stranded RNA viruses belonging to the Picornaviridae 79 family. These viruses make up the largest subgroup of the Enterovirus genus and consist of 80 approximately 30 serotypes. Enteroviruses are the main causative agents of aseptic meningitis 81 worldwide, with echovirus 9 (E9) and echovirus 30 (E30) amongst the most commonly circulating 82 serotypes (1). The neonatal and infant populations are at greatest risk for developing severe 83 echovirus-induced disease and infection within the first few weeks of life can be fatal (2, 3) . 84 Enteroviral infections are also devastating in Neonatal Intensive Care Units (NICUs), where they 85 account for 15-30% of NICU-associated nosocomial viral infections and result in death of the 86 neonate in as many as 25% of cases (4-7), the majority of which result from echovirus 11 (E11) 87 infections (8). In neonates, vertical transmission may occur at the time of delivery following a 88 maternal infection in the days or weeks prior to delivery (9). In addition, echovirus infections have 89 also been observed in utero, both at late and earlier stages of pregnancy, where they are 90 associated with fetal death (10) (11) (12) (13) (14) . 91 Echoviruses are primarily transmitted through the fecal-oral route where they target the 92 gastrointestinal epithelium. In primary human fetal-derived enteroids, echoviruses exhibit a cell 93 type specificity of infection and preferentially infect enterocytes (15). The basis for this cell-type 94 specific tropism is unclear. Decay accelerating factor (DAF/CD55) functions as an attachment 95 factor for some echoviruses (16), but DAF expression does not sensitize non-permissive cells to 96 infection (17), suggesting that another cell surface molecule functions as the primary receptor. 97 While integrin VLA-2 (a2b1) is a primary receptor for E1 (18), it does not serve as a receptor for 98 other echoviruses. Other work has implicated a role for MHC class I receptors in echovirus 99 infections due to inhibition of viral binding, entry, or infection by monoclonal antibodies to MHC 100 class I and/or beta-2 microglobulin (b2M) (17, 19, 20) , which is required for efficient cell surface 101 4 trafficking of MHC class I receptors. However, the precise role for MHC class I and b2M remains 102 unclear and the primary receptor for many echoviruses is unknown. 103 Here, we identify the human neonatal Fc receptor (FcRn) as a primary echovirus receptor. 104 We show that human cells deficient in FcRn expression are resistant to echovirus infection and 105 infection is restored by FcRn expression. Concomitantly, expression of human FcRn renders 106 murine-derived cell lines and primary cells permissive to echovirus infection. In contrast, 107 expression of the murine homolog of FcRn has no effect on viral infection in either human or 108 mouse cells, identifying a species-specific role for FcRn in echovirus infection. Using primary 109 human intestinal epithelial cell monolayers isolated from mid-gestation fetal small intestines, we 110 show that a monoclonal antibody recognizing b2M, which non-covalently associates with FcRn 111 and is required for FcRn cell surface expression (21), significantly reduces echovirus infection. 112 Lastly, we show that recombinant FcRn in complex with b2M neutralizes echovirus infection and 113 directly interacts with viral particles. Our data thus identify FcRn as a primary receptor for 114 echoviruses, which has important implications for echovirus pathogenesis. 118 We screened a panel of cell lines for their susceptibility to echovirus infection and found that 119 human placental choriocarcinoma JEG-3 cells were resistant to infection by a panel of 7 120 echoviruses (E5-7, E9, E11, E13, and E30) but were highly permissive to the related enterovirus 121 coxsackievirus B3 (CVB) (Figure 1A) . Levels of echovirus infection in JEG-3 cells were 122 comparable to those observed in mouse embryonic fibroblasts (MEFs), which are highly resistant 123 to echovirus infection, and were significantly less than those observed in permissive cell types 124 including human intestinal Caco-2, HeLa, human brain microvascular endothelial cells (HBMEC), 125 and human osteosarcoma U2OS cells (Figure 1A, Supplemental Figure 1A- Figure 1F ). We confirmed the significantly lower levels of expression of FcRn in 141 JEG-3 cells relative to permissive cell lines (HBMEC, HeLa, and JAR) and primary human fetal 142 enteroids using RT-qPCR ( Figure 1D) . In contrast, there were no differences in expression of 143 b2M, which is required to traffic FcRn to the cell surface (21) (Figure 1E ). In addition, we 144 confirmed previous findings that JAR cells are deficient in MHC class I molecules and that JEG-145 3 cells express very low levels of MHC class I molecules (22) (Supplemental Figure 1G) , 146 supporting the notion that these molecules were not responsible for the differential susceptibility 147 of JEG-3 cells to echovirus infections. 148 To determine if the lack of FcRn expression was directly responsible for the low levels of Figure 2D ). 167 To further define the role of hFcRn in echovirus infection, we isolated primary fibroblasts 168 from mice lacking expression of mFcRn, but expressing the a chain of hFcRn under the control 169 of the endogenous promoter (mFcRn -/-hFcRn +/+ ) or matched wild-type controls (mFcRn +/+ hFcRn -170 /-) ( Figure 2C) (23, 24) . In these cells, hFcRn is expressed at the cell surface in complex with 171 mouse b2M. Primary fibroblasts isolated from mFcRn +/+ hFcRn -/mice were resistant to echovirus 172 infection, as expected (Figure 2D, 2E) . In contrast, cells isolated from mFcRn -/-hFcRn +/+ mice 173 were highly permissive to echovirus infection and exhibited >10,000-fold enhanced susceptibility 174 to infection (Figure 2D, 2E) . Collectively, these data show that expression of human, but not 175 mouse FcRn is sufficient to confer cellular susceptibility to echovirus infection, which supports a 176 species-specific role for FcRn in echovirus infections. 7 178 179 We next determined whether loss of FcRn expression rendered cells expressing FcRn less 180 susceptible to infection. For these studies, we used RNAi-mediated silencing of FcRn in HBMEC, 181 an immortalized human blood-brain barrier cell line that expresses high levels of FcRn ( Figure   182 1C, 1D) and which is highly sensitive to echovirus infection (Supplemental Figure 1A, 1B) . We 183 found that silencing of FcRn expression by two independent siRNAs led to significant (~1000-184 10,000-fold) decreases in echovirus infection but had no effect on CVB infection (Figure 3A Figure 3C) . 190 Importantly, echovirus replication in b2M-and hFcRn-RNAi transfected cells was restored when 191 cells were transfected with infectious vRNA (Figure 3C ), suggesting that the inhibition occurred 192 at the stage of virus binding or entry. 193 To determine whether other echoviruses also required expression of FcRn, we performed 194 a high content imaging-based screen using b2M siRNA and two siRNAs targeting FcRn (alone 195 and in combination) for a panel of echoviruses (E5, E6-7, E9, E11, E13, E25, E29, and E30-32) 196 as well as CVB as a control. We found that infection by all echoviruses tested was significantly 197 reduced in cells depleted of b2M or FcRn expression while CVB infection was unchanged 198 (Supplemental Figure 3E ). In addition, consistent with previous studies that blocking antibodies 199 to b2M inhibited infection of E7 and E11 (17, 19) , we found that infection by E5, E7, E9, E11, E13, 200 and E30 were also inhibited by a monoclonal antibody against b2M (Supplemental Figure 3F) . (Figure 3D, right) . 212 Because primary HIE cannot be genetically altered, we used b2M monocloncal antibody to 213 determine whether FcRn also facilitates echovirus infection of these cells. In HIE collected from 214 three different human fetal intestine preparations, we found that b2M monoclonal antibody FcRn facilitates echovirus attachment and directly interacts with viral particles 220 We found that echovirus infection in cells depleted of FcRn could be restored by transfection of 221 cells with vRNA, which suggested that this inhibition occurred at the stage of viral binding or entry. 222 We therefore determined whether downregulation of FcRn expression would alter echovirus 223 binding. We found that silencing of FcRn expression in HBMEC significantly reduced cell surface 224 binding of E5, E7, E9, E11, and E30 to HBMEC (Figure 4A) . In contrast, this silencing had no 225 effect on CVB binding (Figure 4A) . Residual levels of viral binding in HBMEC may be mediated 226 9 by cell surface factors such as DAF that facilitate binding of some echoviruses (16). Consistent 227 with a role in viral binding, we also found that echovirus binding to primary mouse fibroblasts 228 (mFcRn -/-, hFcRn +/+ ) was significantly higher than in cells expressing mFcRn (mFcRn +/+ , hFcRn -/-229 ) ( Figure 4B) . These data show that FcRn facilitates echovirus cell surface attachment. 230 To determine whether FcRn directly interacts with echovirus particles, we used a 231 recombinant protein approach utilizing a purified heterodimer containing the extracellular domain 232 of FcRn in complex with b2M (rFcRn-b2M). We found that incubation of viral particles with rFcRn-233 b2M prior to infection neutralized both E11 and E30 infection (Figure 4C, 4D) . In contrast, 234 incubation with purified b2M alone, or recombinant HLA-A or HLA-C had no effect (Figure 4C , 235 4D). To determine whether there was a direct interaction between FcRn and echoviral particles, 236 we performed in vitro binding assays using rFcRn-b2M. Using this approach, we found that rFcRn-237 b2M co-precipitated with purified E11 and E30 in in vitro binding assays, (Figure 4E) , 238 demonstrating a direct interaction between FcRn and echovirus particles. induced disease is associated with infection of secondary organs, most notably the liver and brain. 261 The expression of FcRn on the surfaces of the intestine, brain microvasculature, and heptocytes 262 may thus explain the tropism of echoviruses for these tissues and the viral mechanism to bypass 263 the barriers presented by the cells comprising these sites. (50). 339 Unless otherwise stated, infections were performed with 1 PFU/cell of the indicated virus. 340 In some cases, viruses were pre-adsorbed to cells for 1hr at 4 o C in serum-free MEM 341 supplemented with 10mM HEPES followed by extensive washing in 1x PBS or complete media. 342 Infections were then initiated by shifting cells to 37 o C for the times indicated. Viral titers were 343 determined by TCID50 assays in HeLa cells using crystal violet staining. 344 Binding assays were performed by pre-adsorbing 50 PFU/cell of the indicated virus to 345 cells for 1hr at 4 o C in serum-free MEM supplemented with 10mM HEPES followed by extensive 346 washing with 1x PBS. Immediately following washing, RNA was isolated, and RT-qPCR 347 performed for viral genome-specific primers, as described below. 348 For experiments using blocking antibodies, cells were incubated with the indicated 
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Human cells deficient in FcRn are non-permissive to echovirus infection
Loss of FcRn expression renders cells resistant to echovirus infection
